Gynae BT 2017

Indications for combined intracavitary/interstitial

•

middle/distal parametrial tumor extension

•

unfavourable topography/unfavourable relation to

the applicator (e.g. asymmetrical tumors)

(depending on applicator position)

•

distal intravaginal tumor growth

•

para-vaginal tumor growth

•

unfavourable topography of organs at risk

(not predictable – correction within the frame of

subsequent applications)